A Multicenter Phase I/II Study of the BCNU Implant (Gliadel ® Wafer) for Japanese Patients with Malignant Gliomas
暂无分享,去创建一个
F. Yamasaki | K. Sugiyama | K. Kurisu | N. Nonoguchi | T. Tominaga | K. Mishima | R. Nishikawa | H. Takeshima | K. Arita | T. Kumabe | Fumi Higuchi | K. Ueki | J. Adachi | T. Aoki | Tetsuya Yamamoto | H. Hirano | E. Ishikawa | M. Matsutani | Shinji Yamashita | S. Yamada | Noriyuki Kawabata
[1] D. Brizel,et al. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .
[2] V. Rohde,et al. First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience , 2010, Neurosurgical Review.
[3] D. Bigner,et al. Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy , 2009, Cancer.
[4] M. McGirt,et al. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. , 2009, Journal of neurosurgery.
[5] E. Pan,et al. A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients , 2008, Journal of Neuro-Oncology.
[6] L. Stribinskiene,et al. A phase II study of radiation with concomitant and then sequential temozolomide (TMZ) in patients (pts) with newly diagnosed supratentorial high grade malignant glioma (MG) who have undergone surgery with carmustine (BCNU) wafer insertion , 2005 .
[7] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[8] A. Dhar,et al. National Institute for Health and Clinical Excellence , 2005 .
[9] Z. Ram,et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. , 2003, Neuro-oncology.
[10] H Kalimo,et al. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. , 1997, Neurosurgery.
[11] S. Piantadosi,et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas , 1995, The Lancet.
[12] S. Piantadosi,et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. , 1995, Lancet.
[13] E. Shpall,et al. Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine. , 1993, Journal of the National Cancer Institute.